PA Study

PA Study™

Understanding the true rationale for the reasons why your product is prior authorized or restricted will enable you to develop strategies to eliminate these obstacles. The PA Study™ determines the methods used by selected managed care customers to restrict the use of your product, assesses the effectiveness of these measures with prescribing physicians, quantifies the adverse impact of these barriers on your sales and identifies ways to mitigate the barriers. We create a “priority list” of customers ranked by both potential incremental revenue and expected success.

Deliverable: A PowerPoint presentation with detailed findings, along with strategic recommendations for reducing formulary restrictions in managed care accounts.